HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary Anne Dooley Selected Research

Therapeutics

10/2021Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
1/2019A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
11/2013Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
11/2011Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
4/2010Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.
2/2010Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation.
5/2009Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
1/2009Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
5/2008Therapy Insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease.
1/2007Human clinical trials in lupus nephritis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary Anne Dooley Research Topics

Disease

22Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2001
13Lupus Nephritis
01/2019 - 01/2001
5Hypertension (High Blood Pressure)
10/2021 - 05/2008
5Glomerulonephritis
02/2014 - 01/2001
5Vasculitis (Vasculitides)
07/2013 - 01/2001
3Thrombosis (Thrombus)
07/2021 - 06/2005
3Chronic Kidney Failure (Chronic Renal Failure)
01/2016 - 11/2011
2Neoplasms (Cancer)
12/2021 - 01/2014
2Rheumatic Diseases (Rheumatism)
07/2021 - 05/2008
2Inflammation (Inflammations)
02/2008 - 07/2002
2Nephritis
01/2007 - 01/2001
1Breast Neoplasms (Breast Cancer)
12/2021
1Skin Neoplasms (Skin Cancer)
12/2021
1Insulin Resistance
10/2021
1Hypertriglyceridemia
10/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021
1Communicable Diseases (Infectious Diseases)
01/2020
1Epilepsy (Aura)
01/2019
1Pre-Eclampsia (Preeclampsia)
01/2019
1Migraine with Aura (Familial Hemiplegic Migraine)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
08/2014
1Vitamin D Deficiency
08/2014
1Hyperlipidemias (Hyperlipidemia)
08/2014
1Kidney Diseases (Kidney Disease)
02/2014
1Chronic Renal Insufficiency
02/2014
1Lymphoma (Lymphomas)
01/2014
1Sjogren's Syndrome (Sjogren Syndrome)
01/2014
1Headache (Headaches)
11/2013
1Hypothyroidism
07/2013
1Body Weight (Weight, Body)
11/2011
1Exanthema (Rash)
04/2010
1Neonatal Systemic lupus erythematosus
04/2010
1Congenital heart block
04/2010
1Nephrotic Syndrome (Syndrome, Nephrotic)
05/2008
1Edema (Dropsy)
05/2008
1Infertility (Sterility)
05/2008
1Autoimmune Diseases (Autoimmune Disease)
01/2007

Drug/Important Bio-Agent (IBA)

9Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 11/2005
6Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2019 - 11/2005
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 01/2007
3Antimalarials (Antimalarial Agents)IBA
12/2021 - 11/2013
3Immunosuppressive Agents (Immunosuppressants)IBA
12/2021 - 02/2006
3GlucocorticoidsIBA
10/2021 - 10/2005
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2010 - 01/2001
2Antinuclear AntibodiesIBA
01/2022 - 08/2012
2hydroxide ionIBA
10/2021 - 08/2014
2Vitamin DFDA LinkGeneric
10/2021 - 10/2005
2Immunoglobulin A (IgA)IBA
07/2021 - 04/2005
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2016
2SteroidsIBA
09/2015 - 01/2014
2Pharmaceutical PreparationsIBA
02/2014 - 07/2013
2Azathioprine (Imuran)FDA LinkGeneric
01/2014 - 11/2011
2AutoantibodiesIBA
11/2013 - 01/2007
24-hydroxycyclophosphamideIBA
07/2013 - 09/2012
2CreatinineIBA
11/2011 - 01/2009
2Anticardiolipin AntibodiesIBA
12/2005 - 06/2005
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
12/2005 - 06/2005
2Estrogens (Estrogen)FDA Link
06/2005 - 07/2002
2Silicon Dioxide (Silica)FDA LinkGeneric
07/2002 - 01/2001
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022
1HDL LipoproteinsIBA
10/2021
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
07/2021
1Urokinase Plasminogen Activator ReceptorsIBA
01/2020
1Contraceptive Agents (Contraceptives)IBA
01/2019
1voclosporinIBA
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1OsteopontinIBA
01/2019
1Calcineurin InhibitorsIBA
01/2019
1Nucleosomes (Nucleosome)IBA
12/2017
1C-Reactive ProteinIBA
08/2014
125-hydroxyvitamin DIBA
08/2014
1fexofenadine (Allegra)FDA LinkGeneric
02/2014
1EnzymesIBA
02/2014
1Flurbiprofen (Froben)FDA LinkGeneric
02/2014
1Cytochrome P-450 CYP3AIBA
02/2014
1Cytochrome P-450 CYP2C9IBA
02/2014
1Methotrexate (Mexate)FDA LinkGeneric
01/2014
1Immunologic Factors (Immunomodulators)IBA
01/2014
1IsoenzymesIBA
07/2013
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
09/2012
1AntibodiesIBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1Uridine Diphosphate (UDP)IBA
11/2010
1Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
11/2010
1Prednisone (Sone)FDA LinkGeneric
04/2010
1SS-A antibodiesIBA
04/2010
1Intravenous Immunoglobulins (IVIG)FDA Link
04/2010
1Serum AlbuminIBA
01/2009
1mycophenolic acid glucuronideIBA
01/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Antiphospholipid AntibodiesIBA
05/2008
1LigandsIBA
02/2008
1Peroxidase (Myeloperoxidase)IBA
10/2007

Therapy/Procedure

12Therapeutics
10/2021 - 10/2005
1Contraindications
01/2019
1Remission Induction
01/2019
1Time-to-Treatment
11/2011
1Complementary Therapies (Alternative Medicine)
05/2008
1Treatment Delay
05/2008
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2007